chr11-57598275-C-T
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_000062.3(SERPING1):c.5C>T(p.Ala2Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,557,632 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A2A) has been classified as Likely benign.
Frequency
Consequence
NM_000062.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SERPING1 | NM_000062.3 | c.5C>T | p.Ala2Val | missense_variant | 2/8 | ENST00000278407.9 | |
SERPING1 | NM_001032295.2 | c.5C>T | p.Ala2Val | missense_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SERPING1 | ENST00000278407.9 | c.5C>T | p.Ala2Val | missense_variant | 2/8 | 1 | NM_000062.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000992 AC: 151AN: 152152Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00125 AC: 201AN: 160658Hom.: 1 AF XY: 0.00151 AC XY: 130AN XY: 86220
GnomAD4 exome AF: 0.00135 AC: 1897AN: 1405362Hom.: 5 Cov.: 32 AF XY: 0.00137 AC XY: 954AN XY: 693868
GnomAD4 genome AF: 0.000992 AC: 151AN: 152270Hom.: 0 Cov.: 31 AF XY: 0.000860 AC XY: 64AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 02, 2020 | Reported in patients with angioedema in published literature; observed in the unaffected father of one patient (Gosswein et al., 2008; Rasmussen et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32896191, 31488451, 18758157) - |
C1 inhibitor deficiency;C2717906:Hereditary angioedema type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | SERPING1 NM_000062.2 exon 2 p.Ala2Val (c.5C>T): This variant has been reported in the literature in 2 individuals with hereditary angioedema, segregating with disease in at least 2 affected family members (Gosswein 2008 PMID:18758157). However, this variant is present in 0.3% (84/23494) of South Asian alleles, including 1 homozygote in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs185342631). This variant is present in ClinVar (Variation ID:305016). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Hereditary angioedema type 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at